Name | Number of supported studies | Average coverage | |
---|---|---|---|
mast cell | 16 studies | 24% ± 11% | |
endothelial cell | 10 studies | 25% ± 9% | |
glutamatergic neuron | 8 studies | 39% ± 23% | |
adipocyte | 8 studies | 29% ± 7% | |
GABAergic neuron | 6 studies | 33% ± 17% | |
neuron | 5 studies | 20% ± 6% | |
astrocyte | 5 studies | 27% ± 7% | |
interneuron | 5 studies | 30% ± 14% | |
lymphocyte | 3 studies | 21% ± 3% | |
hepatocyte | 3 studies | 30% ± 19% | |
endothelial cell of lymphatic vessel | 3 studies | 17% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 1143.23 | 245 / 245 | 100% | 11.08 | 502 / 502 |
ovary | 100% | 1596.47 | 180 / 180 | 100% | 7.83 | 428 / 430 |
brain | 100% | 1358.05 | 2629 / 2642 | 100% | 11.87 | 704 / 705 |
liver | 100% | 1369.83 | 226 / 226 | 99% | 13.71 | 403 / 406 |
intestine | 100% | 1299.62 | 966 / 966 | 98% | 8.00 | 519 / 527 |
stomach | 100% | 791.20 | 358 / 359 | 99% | 8.22 | 282 / 286 |
thymus | 99% | 778.51 | 648 / 653 | 99% | 8.62 | 599 / 605 |
esophagus | 100% | 984.96 | 1442 / 1445 | 98% | 7.40 | 180 / 183 |
kidney | 100% | 1046.67 | 89 / 89 | 98% | 11.22 | 883 / 901 |
uterus | 100% | 1607.88 | 170 / 170 | 97% | 7.98 | 446 / 459 |
breast | 100% | 2691.80 | 459 / 459 | 97% | 8.32 | 1085 / 1118 |
lung | 99% | 775.22 | 571 / 578 | 98% | 6.68 | 1134 / 1155 |
pancreas | 94% | 527.18 | 308 / 328 | 99% | 8.47 | 177 / 178 |
skin | 100% | 1666.08 | 1808 / 1809 | 90% | 6.61 | 423 / 472 |
bladder | 100% | 1347.29 | 21 / 21 | 88% | 6.36 | 444 / 504 |
adrenal gland | 93% | 496.33 | 240 / 258 | 93% | 6.73 | 214 / 230 |
adipose | 100% | 3427.49 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1187.88 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 901.81 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 7.66 | 45 / 45 |
heart | 98% | 740.92 | 845 / 861 | 0% | 0 | 0 / 0 |
muscle | 98% | 650.81 | 788 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 83% | 4.17 | 24 / 29 |
eye | 0% | 0 | 0 / 0 | 66% | 2.87 | 53 / 80 |
peripheral blood | 50% | 425.80 | 462 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0022400 | Biological process | regulation of opsin-mediated signaling pathway |
GO_0018008 | Biological process | N-terminal peptidyl-glycine N-myristoylation |
GO_0075733 | Biological process | intracellular transport of virus |
GO_0043657 | Cellular component | host cell |
GO_0005829 | Cellular component | cytosol |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0005886 | Cellular component | plasma membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0018030 | Molecular function | peptidyl-lysine N6-myristoyltransferase activity |
GO_0004379 | Molecular function | glycylpeptide N-tetradecanoyltransferase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | NMT2 |
Protein name | Glycylpeptide N-tetradecanoyltransferase (EC 2.3.1.97) Glycylpeptide N-tetradecanoyltransferase 2 (EC 2.3.1.97) (Myristoyl-CoA:protein N-myristoyltransferase 2) (NMT 2) (Peptide N-myristoyltransferase 2) (Protein-lysine myristoyltransferase NMT2) (EC 2.3.1.-) (Type II N-myristoyltransferase) |
Synonyms | |
Description | FUNCTION: Adds a myristoyl group to the N-terminal glycine residue of certain cellular and viral proteins . Also able to mediate N-terminal lysine myristoylation of proteins: catalyzes myristoylation of ARF6 on both 'Gly-2' and 'Lys-3' . Lysine myristoylation is required to maintain ARF6 on membranes during the GTPase cycle . . FUNCTION: Adds a myristoyl group to the N-terminal glycine residue of certain cellular proteins. . FUNCTION: Adds a myristoyl group to the N-terminal glycine residue of certain cellular proteins. . FUNCTION: Adds a myristoyl group to the N-terminal glycine residue of certain cellular proteins. . |
Accessions | ENST00000378165.9 ENST00000378150.1 Q5VUC6 Q5VUC7 O60551 Q9BS83 |